Innova Capital, a CEE private equity fund, is to acquire 33 per cent of the shares in OSHEE, a provider of isotonic and functional drinks in the Polish market. In the last 10 years, OSHEE became the indisputable leader on the Polish sports and vitamin functional beverage market, selling its

Lotus Clinical Research (Lotus) of Pasadena, California, has entered into a private equity partnership with DFW Capital Partners and has added Jeffrey Kinell and Kurt Brykman to its board of directors in conjunction with the investment. Kinell was previously the CEO of Bracket Global, a leader in the clinical trials technology space,

Salveo Capital, an alternative investment firm specialising in the legalised cannabis space, has completed an investment in Harborside.   The investment, which is part of a Series B funding for Harborside, will help facilitate the company’s expansion throughout California and further improve its supply chain.   Founded in 2006, Harborside

A business which allows recruiters to test the skills of IT professionals and hire the right people has secured a GBP500,000 investment from the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Fund Managers. The investment, which is the first by the North

Feedr, an intelligent lunch platform that uses technology to offer office employees personalised meals from healthy food suppliers, has secured a pre-Series A investment round of GBP1.535 million.   The round was supported by notable investors including Episode 1 – the Venture Capital fund who backed Shazam and Triptease, as

FairMoney, a fair loan comparison website, has commenced its pre-series fundraising found of GBP1 million. The funds raised will be used primarily for enhanced targeted customer marketing efforts, including machine intelligence, to provide customers with the very best and fairest deals for them. It will target the areas of the

DIP Capital’s Disruption Investment Platform (DIP) Fund I has invested GBP1.5 million in wejo, a leading UK technology company which collates data from connected vehicles. DIP Capital was established in February 2018 and focuses on investing in disruptive businesses. Founded and led by Riccardo Cirillo, DIP has a first fund

Camel-IDS, a VUB spin-off company developing cancer-targeted radio-pharmaceuticals, has secured EUR37 million in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co- lead investors HealthCap (Sweden), Novo Seeds (Denmark), Pontifax (Israel) and BioMedPartners (Switzerland). Existing investors also participated. The proceeds will enable